Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer.
暂无分享,去创建一个
Y. Tsutsumi | T. Mayumi | H. Mizuguchi | S. Nakagawa | K. Ikeda | K. Saeki | K Ikeda | N Utoguchi | N. Utoguchi | S Nakagawa | T Mayumi | H Mizuguchi | Y Tsutsumi | K Saeki
[1] H. Maeda,et al. Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer. , 1988, The Journal of biological chemistry.
[2] H. Maeda,et al. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. , 1992, Bioconjugate chemistry.
[3] D. Rotrosen,et al. Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers , 1986, The Journal of cell biology.
[4] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[5] H. Movat,et al. Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeability. , 1986, The American journal of pathology.
[6] A. Malik,et al. Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin. , 1989, The American journal of physiology.
[7] T. Mayumi,et al. A comparison of drug transport through cultured monolayers of bovine brain capillary and bovine aortic endothelial cells. , 1994, Biological & pharmaceutical bulletin.
[8] P. Phillips,et al. Direct staining and visualization of endothelial monolayers cultured on synthetic polycarbonate filters. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[9] J. Cooper,et al. Molecular sieving characteristics of the cultured endothelial monolayer , 1987, Journal of cellular physiology.
[10] James M. Anderson,et al. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells , 1988, The Journal of cell biology.
[11] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[12] H. Dvorak,et al. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.
[13] P Delorme,et al. An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.
[14] M. Peach,et al. Role of Endothelial Cell Cytoskeleton in Control of Endothelial Permeability , 1982, Circulation research.
[15] B. Gumbiner,et al. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Siliciano,et al. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia , 1986, The Journal of cell biology.
[17] S. Nakagawa,et al. Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer , 1995, Journal of cellular physiology.
[18] V. V. van Hinsbergh,et al. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. , 1991, The American journal of physiology.
[19] T. Takano,et al. Transcellular transport of fluorescein dextran through an arterial endothelial cell monolayer. , 1986, Cell structure and function.
[20] S. Nakagawa,et al. Glial extracellular matrix modulates γ-glutamyl transpeptidase activity in cultured bovine brain capillary and bovine aortic endothelial cells , 1994, Brain Research.
[21] E. M. Renkin. Multiple pathways of capillary permeability. , 1977, Circulation research.
[22] Bradbury Mw. The structure and function of the blood-brain barrier. , 1984 .
[23] R. Jain,et al. Pore and fiber-matrix models for diffusive transport in normal and neoplastic tissues. , 1984, Microvascular research.
[24] C. Song,et al. Quantitative study of vascularity in Walker carcinoma 256. , 1971, Cancer research.
[25] Benjamin Geiger,et al. Cingulin, a new peripheral component of tight junctions , 1988, Nature.
[26] H. Maeda,et al. Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor , 1994, Japanese journal of cancer research : Gann.
[27] D. Connolly,et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.
[28] Tetsurou Yamamoto,et al. Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study , 1991, Japanese journal of cancer research : Gann.
[29] M. Mori,et al. Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2 , 1993, The Journal of cell biology.
[30] X. Ding,et al. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.